AIM ImmunoTech Q4 EPS $(0.26) Misses $(0.15) Estimate, Sales $65.00K Beat $40.00K Estimate
AIM ImmunoTech Q4 EPS $(0.26) Misses $(0.15) Estimate, Sales $65.00K Beat $40.00K Estimate
AIM ImmunoTech第四季度每股收益美元（0.26美元）未達到預期（0.15美元），銷售額超過40.00萬美元的預期
AIM ImmunoTech (AMEX:AIM) reported quarterly losses of $(0.26) per share which missed the analyst consensus estimate of $(0.15) by 73.33 percent. This is a 188.89 percent decrease over losses of $(0.09) per share from the same period last year. The company reported quarterly sales of $65.00 thousand which beat the analyst consensus estimate of $40.00 thousand by 62.50 percent. This is a 16.07 percent increase over sales of $56.00 thousand the same period last year.
AIM ImmunoTech（美國證券交易所股票代碼：AIM）公佈的季度虧損爲每股0.26美元，比分析師普遍預期的0.15美元（0.15美元）低73.33％。與去年同期每股虧損0.09美元（0.09）相比，下降了188.89％。該公司公佈的季度銷售額爲65,000美元，比分析師普遍預期的4萬美元高出62.50％。這比去年同期的56,000美元的銷售額增長了16.07％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。